Company: HCWB
Filing Date: 2025-02-07
Form Type: 8-K
Source: 0000950170-25-016390
Chunk: 2

Company: HCW Biologics Inc.
Filing Date: 2025-02-07
Form: 8-K
Item: Item 8.01
Chunk 2
---
Item 8.01 Other Events.

As previously disclosed in the Company’s Form 8-K filed on December 23, 2024, pursuant to applicable Nasdaq Rules, the Company issued a press release on December 23, 2024 announcing receipt of a Nasdaq Staff determination letter, for noncompliance with the MVLS Rule for Nasdaq Global Market tier, as required, with a description of each specific basis and concern identified by Nasdaq in that letter.

Item 9.01 Financial Statements and Exhibits.